Monopar Expands Phase 2b/3 VOICE Clinical Trial to Europe

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/13/2026

1. SKHY
2. SPY
3. USO
4. META
5. SKHYV
6. DAL
7. PEP
8. NFLX
9. MU
10. NRIX

Go back to Monopar Expands Phase 2b/3 VOICE Clinical Trial to Europe
(NASDAQ: MNPR) Delayed: 106.60 --0 (-0%)
Previous Close $106.60    52 Week High $ 
Open $106.60    52 Week Low $ 
Day High $106.60    P/E N/A 
Day Low $106.60    EPS $ 
Volume 1,132